Bioneer Corporation logo

Bioneer Corporation (064550)

Market Open
10 Aug, 06:30
KRX SM KRX SM
7,230. 00
+320
+4.631%
- Market Cap
- P/E Ratio
- Div Yield
77,549 Volume
0 Eps
6,910
Previous Close
Add Transaction
Day Range
7,000 7,270
Year Range
5,470 15,640
Want to track 064550 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

064550 trading today higher at ₩7,230, an increase of 4.631% from yesterday's close, completing a monthly increase of 5.8565% or ₩400. Over the past 12 months, 064550 stock lost -43.4715%.
064550 is not paying dividends to its shareholders.
The last earnings report, released on Apr 30, 2024, missed the consensus estimates by -496.653%. On average, the company has fell short of earnings expectations by -331.102%, based on the last three reports.
Bioneer Corporation has completed 1 stock splits, with the recent split occurring on May 15, 2017.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on KOSDAQ (KRW).

064550 Chart

Bioneer Corporation (064550) FAQ

What is the stock price today?

The current price is ₩7,230.00.

On which exchange is it traded?

Bioneer Corporation is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 064550.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Bioneer Corporation ever had a stock split?

Bioneer Corporation had 1 splits and the recent split was on May 15, 2017.

Bioneer Corporation Profile

Biotechnology Industry
Healthcare Sector
Jin-Pyeong Jeong CEO
KRX SM Exchange
KR7064550007 ISIN
KR Country
608 Employees
- Last Dividend
15 May 2017 Last Split
29 Dec 2005 IPO Date

Overview

Bioneer Corporation, established in 1992 and based in Daejeon, South Korea, is a prominent player in the biotechnology sector. It specializes in a broad range of areas including biotechnology research products, molecular diagnostics, pharmaceuticals, and probiotics. Through its dedication to innovation and quality, Bioneer has carved out a significant presence not only within South Korea but also on the international stage, contributing to advancements in biotechnology research and healthcare solutions.

Products and Services

Bioneer Corporation offers an extensive portfolio of products and services designed to meet the diverse needs of the biotechnology and molecular diagnostics sectors:

  • PCR and RT-PCR, Real-Time PCR: Tools and kits for Polymerase Chain Reaction (PCR), Reverse Transcription PCR (RT-PCR), and quantitative real-time PCR for gene amplification and quantification.
  • RNAi: Solutions for gene silencing through RNA interference (RNAi) technology, aiding in gene function studies and drug discovery.
  • Chemicals, Plastic Consumables, and Buffer Solutions: A range of laboratory necessities for various research and diagnostic purposes, including high-quality chemicals, durable plasticware, and buffer solutions essential for biochemical experiments.
  • Sample Preparation: Products and technologies for efficient sample preparation, critical for accurate molecular analysis and diagnostics.
  • Protein Synthesis and Purification: Comprehensive tools and services for the synthesis, expression, and purification of proteins for research and industrial applications.
  • Gene Cloning: Technologies and services for gene cloning, enabling the study of gene function and protein expression.
  • Fluorescence Dye and Quencher: Essential components for molecular probes in various real-time PCR and molecular diagnostic applications.
  • Electrophoresis: Equipment and supplies for the separation and analysis of macromolecules, such as DNA, RNA, and proteins.
  • Genome-Wide Functional Analysis: Technologies and services for analyzing the functions of genes across the entire genome, facilitating comprehensive biological research and discovery.
  • Magnetic Separation: Solutions for separating and purifying biological molecules and cells using magnetic fields, enhancing sample purity and analysis accuracy.
  • Instruments: A wide array of instruments including those for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixers, electrophoresis, spectrophotometers, and microbial culture, ensuring precision and efficiency in research and diagnostic labs.

In addition to these research-focused products and services, Bioneer also provides:

  • Molecular Diagnosis: Advanced molecular diagnostic (MDx) technologies, human diagnostics kits, MDx extraction kits, and instruments, supporting the accurate diagnosis of diseases.
  • Animal Disease Products: Specialized diagnostics and products for the management of animal diseases, contributing to veterinary health and agricultural productivity.
  • Nano-Bio Products: Innovative solutions that leverage nanotechnology for biomedical and biotechnological applications, opening new avenues in drug delivery and diagnostic assays.

Contact Information

Address: 8-11, Munpyeongseo-ro, Daejeon, South Korea
Phone: 82 1 588 9788